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Background: Soil-transmitted helminths (STH) are among the most common parasitic
infections globally, disproportionately affecting children. Treatment of STH in Kenya
is often targeted at preschool (PSAC) and school aged (SAC) children delivered
through annual mass drug administration (MDA) in primary schools. Understanding
group-specific prevalence and dynamics between treatment and coverage is critical
for continued treatment success. This study aims to provide detailed information on
group-specific infection prevalence and relative reductions (RR), and their relationships
with treatment coverage over time. Additionally, it aims to quantify the correlation between
the observed school level infection prevalence and treatment coverage.
Methods: Secondary analysis of existing data collected between 2012 and 2018
by the monitoring and evaluation (M&E) program of the National School-Based
Deworming (NSBD) program was used. The M&E program conducted surveys utilizing
cross-sectional study design, at four survey time points, in a nationally-representative
sample of schoolchildren across counties in Kenya. In each participating school,
the program randomly sampled 108 children per school, of both groups. Infection
prevalencewas estimated using binomial regression, RR in prevalence usingmultivariable
mixed effects model, statistical correlations using structural equation modeling, and
change-point-analysis using the binary segmentation algorithm.
Results: Overall, STH prevalence for PSAC was 33.7, 20.2, 19.0, and 17.9% during
Year 1 (Y1), Year 3 (Y3), Year 5 (Y5), and Year 6 (Y6) surveys, respectively with an overall
RR of 46.9% (p = 0.001) from Y1 to Y6. Similarly, overall STH prevalence for SAC was
33.6, 18.4, 14.7, and 12.5% during Y1, Y3, Y5, and Y6 surveys, respectively with an
overall RR of 62.6% (p < 0.001). An overall (all time points) significant but very weak
negative correlation was found between treatment coverage and undifferentiated STH
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prevalence (r = −0.144, p = 0.002) among PSAC but not in SAC. Further, we observed
inter-county heterogeneity variation in infection prevalence, RR, as well as correlations.
Conclusion: The analysis showed that after six rounds of MDA, prevalence of STH has
significantly declined among both groups of children, however not to a point where it is
not a public health problem (below 1%). The analysis, additionally established an overall
significant but weak negative correlation between treatment coverage and prevalence,
indicating that the current treatment coverage might not be sufficient to drive the overall
STH prevalence to below 1%. These findings will allow STH control programs in Kenya
to make decisions that will accelerate the attainment of STH elimination as a public
health problem.
Keywords: correlation analysis, soil-transmitted helminths, treatment coverage, school-based deworming,
prevalence, Kenya
INTRODUCTION
Soil-transmitted helminths (STH) primarilyAscaris lumbricoides,
Trichuris trichuira, and the hookworms; Necator americanus
and Ancylostoma duodenale are among the most widespread
neglected tropical diseases (NTDs) globally, affecting more
than 1.5 billion people each year (1). The current World
Health Organization (WHO) guidelines for the control of
STH recommend provision of treatment through mass drug
administration (MDA) to vulnerable groups, namely, preschool
aged children (PSAC), school aged children (SAC), and women
of childbearing age (WCA) (2–4). Under the guidelines both
infection monitoring and treatment through MDA focus
primarily on treatment frequency driven by undifferentiated
prevalence for SAC, with MDA recommended for PSAC and
WCA in situations where sustainable delivery mechanisms
exist (2).
The focus of the current guidelines on SAC is in recognition
that the highest burden of infection generally falls among this
group, with subsequent risk of detrimental impact on growth (5)
and development (6). The WHO also recognizes the substantial
burden of infection among PSAC and the need to scale up
coverage of MDA to reach 75% among PSAC as well as SAC
by 2020 (3, 7, 8). Treatment coverage and resulting prevalence
have shown mixed trends globally, with some countries lagging
behind (9). Despite this, many countries have made considerable
gains in increasing treatment coverage for SAC, however, less
than half of endemic countries also target treatment toward
PSAC. These countries yield low coverage levels of ∼50% with
considerable variability of coverage year on year and across their
geography (10). Understanding prevalence and coverage, but also
how the two interact across key age-groups is key to future
deworming efforts.
Abbreviations: CIs, Confidence intervals; DEC, Diethylcarbamazine citrate; ECD,
Early childhood development; MDA,Mass drug administration;M&E,Monitoring
and evaluation; NSBD, National school based deworming; NTDs, Neglected
tropical diseases; PSAC, Preschool aged children; RR, Relative reduction; SAC,
School aged children; SEM, Structural equation model; STH, Soil-transmitted
helminths; WASH, Water sanitation and hygiene; WCA, Women of childbearing
age; WHO, World Health Organization; Y1, Year 1; Y3, Year 3; Y5, Year 5;
Y6, Year 6.
The Kenyan National School Based Deworming (NSBD)
program was launched in 2012 with the aim of reducing the
burden of the disease among SAC. The program provides annual
MDA to 66 endemic sub-counties spread out across four endemic
regions; Western, Nyanza, Rift Valley, and Coast and three
regions with minimal risk; Central, Eastern and North Eastern
(11, 12). The NSBD program which forms a key component
of the country’s national response strategy to control STH and
schistosome infections, as a public health problem, functions
by administering treatment to all SAC including those out of
school (in this case PSAC). The program has so far offered
consistent and high MDA coverage for the last 6 years, with
some variation at the county level (13). The program’s impact,
both in terms of treatment coverage and infection control, has
been consistently monitored through a robust monitoring and
evaluation (M&E) program (14). In large part due to the success
of the program, national STH infection levels among school
children have declined, as reported by the M&E component of
the NSBD program (14–17).
Previous studies (14–17) have described the prevalence and
intensity of helminth infection using the Kenyan M&E data
across seven years of the program, however, undifferentiated
between PSAC and SAC. There has also yet to be correlational
analysis performed for risk of infection stratified by treatment
coverage across counties covered by the NSBD program.
Recognizing the importance of understanding levels and drivers
of infection differentiated among PSAC and SAC, we combine
pre-existing datasets on treatment coverage and infection
prevalence to provide detailed trend correlational, and change-
point analyses for counties covered by the NSBD program. This
is with the aim of better informing STH control programs to
make decisions that will accelerate the attainment of elimination
of STH as a public health problem in Kenya.
MATERIALS AND METHODS
This was a secondary analysis of existing data collected as part
of the M&E component of the Kenyan NSBD program. The
study utilized secondary data to; differentiate prevalence between
PSAC and SAC for the 6 years of the NSBD, then identify
any correlations between changes in treatment coverage at the
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county level and risk of STH infection. Finally, a change point
analysis was performed to demonstrate tipping points at which
the greatest reductions in prevalence can be seen relative to
changes in coverage. Data was drawn from two primary sources;
prevalence surveys and MDA coverage monitoring performed as
part of the NSBD program. Both datasets and details of analyses
performed are described below.
Prevalence Data
Large scale surveys for STH prevalence have been conducted at
Year 1 (Y1), Year 3 (Y3), Year 5 (Y5), and Year 6 (Y6) since the
NSBD inception. Detailed design for these surveys are provided
in previous studies (14–17). Briefly, all previous surveys utilized
a cross-sectional study design in a nationally-representative,
stratified, two-stage sample of schoolchildren across counties in
Kenya. For Y1, Y3, and Y5 surveys, an average of 200 schools per
survey round in 16 counties in four regions; Western, Nyanza,
Rift Valley, and Coast were surveyed before treatment to measure
national infection levels. However, for the Y6 survey, 100 schools
(5 schools per county) were sampled in 20 counties in six regions;
Western, Nyanza, Rift Valley, Coast, Eastern and North Eastern.
In each of the sampled schools, 18 children (nine girls and
nine boys) were sampled randomly from each of the six classes,
including one early childhood development (ECD) class and
classes 2–6, using random numbers, for a total of ∼108 children
per school. During each survey point, the program processed and
examined in duplicate single stool samples from each selected
child for identification of STH eggs using the Kato-Katz thick
smear technique (16, 18).
Specifically for this study, we structured our analysis by two
age groups of children as defined by the Kenyan Ministry of
Education; PSAC (children aged 2–4 years) and SAC (children
aged 5–14 years) to determine the trend in infection prevalence
and its correlation with treatment coverage in the two age groups.
This kind of age structured analysis will allow comparability of
our results to many other age-structured STH modeling work.
The infection prevalence was defined as the number of
children tested positive for each infection divided by the total
number of children examined in the school. On the other hand,
school level infection prevalence was defined as the averaged
infection prevalence observed among schoolchildren surveyed
at that school (sample size of 108 children). In this analysis, we
determined infection prevalence for two age groups separately,
being prevalence data for PSAC and SAC during the four
survey time points; Y1, Y3, Y5, and Y6 pre-treatment surveys,
so as to enable the calculation of the trend in prevalence and
relative reduction (RR) over the 6-year period in the modeling.
The overall relative reduction in prevalence was defined as the
difference in the infection prevalence between Y1 and Y6 surveys.
Figure 1 shows the number of schools extracted from the
NSBDP’sM&E database and the number included in this analysis.
The M&E program planned to follow the same number of
schools (200 schools during Y1 to Y5 and 100 schools during Y6)
longitudinally each survey year, however, the following situations
led to the final number of schools included in this analysis being
inconsistent at some survey points: (1) 27 schools were surveyed
too close to Y3 survey hence their time for reinfection was much
shorter than the rest of the schools and they were deemed to
overestimate the treatment impact. These schools were excluded
from the analysis. (2) Some schools had no ECD centers hence
they did not have data for PSAC. Such schools were therefore
excluded in the analysis for PSAC data. (3) One school was found
to be closed down after Y3 survey and was therefore not surveyed
during Y5, this school was excluded from the analysis. (4) After
Y5 survey, the M&E plan was changed and provided for survey
of only 100 schools (five schools per county) during Y6 survey.
Taking into account all these situations that led to inconsistent
number of schools in some survey years especially among PSAC
group and the fact that same number of children were randomly
sampled in each school, the analysis objective, which was to
determine trend in infection prevalence and its correlation with
treatment coverage all aggregated at the county level, was not
significantly affected by this inconsistency.
Treatment Coverage Data
Treatment coverage information for each school is usually
recorded within the NSBD program by Evidence Action; an
international non-governmental organization, who provides
technical support to the government’s NSBD program. School-
level treatment coverage for each infection were aggregated
and presented at the sub-county level. Treatment coverage was
determined as the number of children who received treatment
for each infection divided by the number targeted at each
participating school. Similarly, we calculated the previous year’s
treatment coverage levels for each of the two age groups
separately during the four survey time points with the exception
of Y1 survey since there was no previous year treatment.
Treatment for STH infections was offered annually to the
targeted children using single dose of albendazole in 28 counties
in Kenya, consecutively for 6 years. All the 20 counties included
in the M&E program were covered for treatment following the
WHO guidelines (19). Importantly, treatment was delivered at
school level.
Statistical Analyses
The analysis was conducted for two groups of children (PSAC
and SAC) dewormed at the participating schools. The PSAC
group of children was defined as those children aged 2–
4 years and may not be necessarily enrolled in the school,
who were dewormed after presenting themselves at the nearby
participating primary school on the deworming day. The
SAC group of children was defined as those children aged
5–14 years and enrolled in the primary school, and who
were dewormed at their participating primary school on the
deworming day.
Infection prevalence, amongst each group of children,
was defined as the number of children who were
tested positive for a particular STH infection using
the Kato-Katz technique by the NSBD program (i.e.,
Prevalence =
(
Number of children positive
Number of children examined
)∗
100%). For each
prevalence estimate calculated, the 95% confidence intervals
(CIs) were determined using binomial regression model, taking
into account clustering by schools. The relative reductions
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FIGURE 1 | Schema illustrating the number of schools extracted from the NSBDP’s M&E database and the number of schools included in this analysis.
in STH infection prevalence for each group of children was
defined as the difference in prevalence between Y1 and Y6
surveys (i.e., RR =
(




and RR estimates calculated using multivariable mixed effects
models with random intercepts for schools and counties, and
the associated p-values obtained using Wald test. Hence, RR
reflected the infection prevalence reduction levels after treatment
(in this case, after five rounds of treatment) in comparison with
the initial (Y1) prevalence.
Statistical correlations (r) between infection prevalence and
the previous year’s treatment coverage were determined at
county-level and the p-values estimated using structural equation
modeling (SEM), allowing for variations across school clusters.
The structure of the SEM model used is shown in Appendix A1.
The decision to use SEM over an ordinary correlation model
was based on its ability to simultaneously perform statistical tests
while handling missing data more elegantly (20, 21). Further,
the correlation analysis was stratified by county since each
county represents a different transmission pattern and dynamics.
Significance levels, for either RR or correlations, were set at
p ≤ 0.05.
Further, we conducted change point analysis in order to
investigate the survey year points associated with significant
changes in infection prevalence over the 6 year period, following
the yearly MDAs. Briefly, change point analysis helps solve
the problem of estimating point(s) at which some statistical
properties (e.g., mean) of a time series data show significant
change, potentially as a result of an intervention (or lack thereof).
More information on the methodology and implementation of
this technique is well-illustrated in previous studies (22, 23).
In this analysis, we detected significant change point(s) along
the 6 year implementation period of the program using the
binary segmentation algorithm implementable in the R package
“changepoint” (24).
Statistical analyses were carried out using either STATA
version 14.1 (STATA Corporation, College Station, TX, USA)
or R statistical software (25), where appropriate. All graphs
were developed using the ggplot package implemented in R











































TABLE 1 | Number of schools (children) examined, undifferentiated STH pre-treatment prevalence % (95% CI), and relative reductions % (Wald test: Z-statistic, p-value) by county for preschool (PSAC) and school
(SAC) aged group of children in 20 counties in Kenya.
County Number of schools (children) examined Undifferentiated STH pre-treatment prevalence %(95%CI) Relative Reduction
(Year 1–Year 6)
Year 1 Year 3 Year 5 Year 6 Year 1 Year 3 Year 5 Year 6 RR% (Wald test, p-value)
PSAC Group
Bomet 11 (88) 9 (99) 11 (139) 5 (39) 46.6 (30.9–70.1) 31.3 (18.1–54.1) 20.9 (14.6–29.8) 20.5 (13.8–30.4) 56.0 (Z = −3.11, p = 0.002)*
Bungoma 9 (93) 10 (102) 10 (138) 5 (60) 54.8 (43.5–69.2) 20.6 (12.8–33.1) 15.9 (10.0–25.3) 8.5 (1.9–37.4) 84.5 (Z = −2.56, p = 0.011)*
Busia 17 (118) 17 (111) 18 (268) 5 (28) 33.1 (22.2–49.2) 26.1 (19.4–35.3) 17.7 (11.4–27.4) 28.6 (10.8–75.5) 13.6 (Z = −0.33, p = 0.738)
Garissa -ns -ns -ns 5 (20) -ns -ns -ns 0 -ns
Homa Bay 24 (422) 23 (211) 21 (121) 3 (7) 23.9 (18.2–31.5) 17.5 (11.5–26.7) 8.3 (4.0–16.9) 57.1 (24.7–73.2) Increase (38.8%, p = 0.031)**
Kakamega 19 (177) 18 (175) 19 (254) 5 (42) 44.1 (34.1–56.9) 17.7 (9.2–34.2) 14.9 (9.7–22.7) 26.8 (12.4–58.0) 39.1 (Z = −1.32, p = 0.187)
Kericho 12 (161) 10 (96) 12 (166) 5 (37) 38.5 (29.3–50.6) 24.0 (15.6–36.8) 28.5 (19.7–41.3) 21.6 (18.4–25.4) 43.9 (Z = −3.95, p < 0.001)*
Kilifi 3 (25) 2 (5) 2 (13) 5 (57) 28.0 (18.6–42.1) 20.0 (2.8–32.6) 0 1.8 (0.3–10.7) 93.7 (Z = −2.58, p = 0.010)*
Kisii 11 (101) 12 (85) 12 (117) 5 (70) 46.5 (36.9–58.6) 34.1 (28.5–40.8) 26.5 (18.8–37.4) 36.2 (24.2–54.3) 22.1 (Z = −1.32, p = 0.186)
Kisumu 10 (181) 10 (89) 9 (76) 5 (14) 21.5 (14.9–31.1) 2.2 (0.7–7.3) 2.6 (0.6–12.2) 7.1 (1.2–41.4) 66.8 (Z = −1.34, p = 0.181)
Kitui -ns -ns -ns 5 (29) -ns -ns -ns 0 -ns
Kwale 9 (98) 10 (52) 10 (191) 5 (33) 25.5 (15.7–41.4) 7.7 (3.4–17.3) 6.4 (3.9–10.3) 12.1 (7.0–21.1) 52.5 (Z = −2.60, p = 0.009)*
Makueni -ns -ns -ns 4 (12) -ns -ns -ns 0 -ns
Migori 8 (127) 8 (83) 8 (78) 5 (66) 18.9 (12.8–27.8) 1.2 (0.2–8.1) 3.9 (0.7–21.9) 4.5 (2.5–8.2) 75.9 (Z = −3.64, p < 0.001)*
Mombasa 3 (41) 2 (19) 3 (42) 5 (33) 14.6 (3.7–58.6) 10.5 (7.7–14.3) 0 3.0 (0.5–17.6) 79.3 (Z = −1.53, p = 0.127)
Narok 10 (99) 7 (75) 9 (83) 5 (61) 55.6 (43.5–70.9) 36.0 (21.1–61.3) 45.8 (31.2–67.2) 37.7 (19.2–74.1) 32.1 (Z = −1.19, p = 0.235)
Nyamira 9 (101) 9 (67) 9 (99) 4 (63) 38.6 (27.9–53.4) 29.9 (19.8–45.0) 30.3 (23.1–39.8) 45.2 (35.4–57.6) Increase (17.0%, p = 0.338)
Taita Taveta 3 (32) 3 (32) 3 (34) 5 (72) 9.4 (2.0–43.3) 0 2.9 (0.3–33.4) 0 100 (Z = −3.03, p = 0.002)*
Vihiga 8 (85) 8 (65) 8 (151) 5 (31) 47.1 (39.8–55.6) 27.7 (20.3–37.7) 41.5 (26.3–65.4) 29.0 (16.9–49.8) 38.3 (Z = −1.73, p = 0.084)
Wajir -ns -ns -ns 3 (7) -ns -ns -ns 0 -ns
Overall 166 (1,949) 159 (1,366) 164 (1,992) 94 (781) 33.7 (30.4–37.4) 20.2 (17.1–23.9) 19.0 (15.9–22.6) 17.9 (13.4–23.9) 46.9 (Z = −4.44, p = 0.001)*
SAC Group
Bomet 12 (1,177) 12 (1,185) 12 (1,132) 5 (499) 29.1 (19.7–42.9) 22.8 (15.0–34.6) 17.7 (11.0–28.5) 24.2 (16.6–35.2) 16.7 (Z = −0.71, p = 0.476)
Bungoma 10 (921) 10 (920) 10 (895) 5 (456) 48.6 (41.4–57.2) 9.1 (7.2–11.5) 6.1 (3.9–9.6) 4.7 (2.5–8.8) 90.3 (Z = −8.16, p < 0.001)*
Busia 18 (1,757) 18 (1,780) 18 (1,641) 5 (497) 36.3 (31.6–41.6) 26.0 (19.3–35.0) 16.8 (12.1–23.4) 23.4 (9.0–61.0) 35.5 (Z = −1.04, p = 0.297)
Garissa -ns -ns -ns 5 (177) -ns -ns -ns 0 -ns
Homa Bay 24 (2,100) 24 (2,238) 23 (2,300) 5 (527) 31.2 (25.6–38.2) 16.3 (11.4–23.4) 11.7 (7.6–18.0) 22.6 (17.7–28.9) 27.6 (Z = −2.27, p = 0.023)*
Kakamega 20 (1,885) 20 (1,869) 20 (1,801) 5 (490) 29.7 (24.3–36.4) 15.6 (10.9–22.5) 9.1 (5.9–14.0) 23.8 (17.3–32.8) 19.8 (Z = −1.26, p = 0.206)
Kericho 12 (1,107) 12 (1,189) 12 (1,094) 5 (498) 28.1 (20.1–39.3) 16.1 (10.9–22.5) 20.0 (13.3–30.1) 16.8 (13.2–21.4) 40.3 (Z = −2.87, p = 0.004)*
Kilifi 3 (279) 3 (282) 3 (280) 5 (444) 33.3 (31.1–35.7) 5.0 (3.3–7.4) 2.2 (1.4–3.4) 5.3 (1.4–19.6) 84.2 (Z = −2.78, p = 0.005)*
Kisii 12 (1,178) 12 (1,171) 12 (1,141) 5 (456) 46.9 (40.6–54.1) 25.6 (19.5–33.6) 23.6 (17.7–31.4) 19.6 (12.4–31.1) 58.1 (Z = −4.86, p < 0.001)*
Kisumu 10 (887) 10 (927) 10 (984) 5 (524) 16.6 (11.9–23.2) 5.0 (3.3–7.4) 4.1 (2.8–6.1) 3.1 (1.2–7.8) 81.5 (Z = −3.68, p < 0.001)*
Kitui -ns -ns -ns 5 (509) -ns -ns -ns 0.4 (0.1–1.3) -ns











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(26). Maps for school-level prevalence overlaid with their
respective subcounty-level treatment coverage were developed
using ArcGIS Desktop version 10.2.2 software (Environmental
Systems Research Institute Inc., Redlands, CA, USA).
RESULTS
Number of Schools and Children Included
in the Study
For PSAC group, during Y1, Y3, Y5, and Y6 pre-treatment survey
points, children aged 2–4 years were included in the analysis
in 166 schools (1,949 children), 159 schools (1,366 children),
164 schools (1,992 children), and 94 schools (781 children),
respectively. The number of schools and PSAC children included
in the final analysis per county at each survey time point is
shown in Table 1. The mean age of PSAC children was 3.7 years
(standard deviation 0.5 years) with 51.0% being females.
For SAC group, during Y1, Y3, Y5, and Y6 pre-treatment
survey points, children aged 5–14 years were included in the
analysis in 173 schools (16,134 children), 173 schools (16,528
children), 172 schools (15,973 children), and 100 schools (8,936
children), respectively. The number of schools and SAC children
included in the final analysis per county at each time point is
shown in Table 1. The mean age of SAC children was 10.1 years
(standard deviation 2.1 years) with 50.2% being females.
Treatment Coverage
Overall treatment coverage for PSAC, for each annual MDA from
Y1 through to Y6 was 21.6, 82.4, 91.9, 87.5, 75.0, and 84.8%,
respectively. Treatment coverage varied within counties across
different years of MDA. Across all years there were counties
that did not reach WHO recommended MDA coverage of ≥75%
coverage (4, 27). In Y1 no county reached ≥75%, in Y2 seven
counties, in Y3 one county, in Y4 three counties, in Y5 five
counties, and in Y6 five counties. County-level summary of the
PSAC STH treatment coverage is outlined in Table 2.
For SAC, the overall STH treatment coverage for each annual
MDA from Y1 through Y6 was high, at 78.6, 80.2, 82.2, 79.6, 80.3,
and 89.2%, respectively. During Y1 MDA, three counties did not
achieve treatment coverage of ≥75%, in Y2 eight counties, in Y3
one county, in Y4 three counties, in Y5 five counties, and in Y6
all counties achieved≥75% coverage (Table 2).
PSAC Infection Prevalence
Overall, 33.7% (95% CI: 30.4–37.4%), 20.2% (95% CI: 17.1–
23.9%), 19.0% (95% CI: 15.9–22.6%), and 17.9% (95% CI: 13.4–
23.9%) of PSAC children were infected with at least one STH
species during Y1, Y3, Y5, and Y6 surveys, respectively, with
an overall relative reduction of 46.9% (p = 0.001) from Y1
to Y6 (Table 1). The PSAC prevalence of undifferentiated STH
differed within counties with highest prevalence, during Y6,
observed in Homabay (57.1%) followed by Nyamira (45.2%),
Narok (37.7%) and Kisii (36.2%) and zero prevalence observed
in Garissa, Kitui, Makueni, Taita Taveta, and Wajir counties.
County level relative reduction indicated that only two counties;
Kilifi and Taita Taveta, reduced the PSAC prevalence by over
90% (Table 1). Comparison of the county-level trends in PSAC











































TABLE 2 | County level summary of STH treatment coverage (%) for preschool (PSAC) and school (SAC) aged group of children in 20 counties in Kenya.






































Bomet 361,835 90,532 25.0 72,436 66,889 92.3 78,921 75,191 95.3 83,111 66,978 80.6 71,459 62,122 86.9 71,453 61,209 85.7
Bungoma 574,830 142,113 24.7 146,748 144,725 98.6 169,706 167,233 98.5 204,242 174,960 85.7 196,734 155,710 79.1 184,476 163,125 88.4
Busia 304,959 81,130 26.6 9,7734 87,608 89.6 97,285 90,042 92.6 92,496 86,196 93.2 96,068 86,479 90.0 85,669 79,184 92.4
Garissa -nt -nt -nt 11,674 5,442 46.6 -nt -nt -nt 0 3,410 100 0 282 100 0 1,304 100
Homa Bay 390,599 116,100 29.7 122,890 111,517 90.7 115,687 117,934 101.9 115,425 115,130 99.7 127,874 112,808 88.2 117,224 112,872 96.3
Kakamega 655,996 159,125 24.3 223,596 164,303 73.5 213,334 171,309 80.3 227,888 156,299 68.6 231,328 153,966 66.6 270,597 172,142 63.6
Kericho 219,434 55,951 25.5 66,072 58,417 88.4 68,827 70,042 101.8 73,250 65,515 89.4 70,803 68,198 96.3 72,754 68,361 94.0
Kilifi 386,498 107,647 27.9 152,029 111,083 73.1 148,415 114,997 77.5 133,653 116,830 87.4 142,828 63,434 44.4 113,519 59,554 52.5
Kisii 485,344 154,395 31.8 129,635 135,292 104.4 115,767 147,113 127.1 119,848 140,307 117.1 126,756 135,406 106.8 107,293 133,155 124.1
Kisumu 325,997 81,232 24.9 135,127 80,416 59.5 111,586 84,986 76.2 115,260 74,961 65.0 121,750 74,106 60.9 155,070 78,981 50.9
Kitui -nt -nt -nt 6,641 7,426 111.8 -nt -nt -nt 0 1,461 100 0 37 100 0 199 100
Kwale 222,952 57,224 25.7 78,543 56,885 72.4 72,943 68,997 94.6 72,846 65,519 89.9 -nt -nt -nt 45,124 9,089 20.1
Makueni -nt -nt -nt 19,518 14,713 75.4 -nt -nt -nt 0 10,625 100 -nt -nt -nt 0 847 100
Migori 387,226 122,454 31.6 124,687 112,646 90.3 121,587 109,443 90.0 121,832 109,808 90.1 129,346 111,460 86.2 140,927 126,102 89.5
Mombasa 171,418 44,979 26.2 82,343 53,718 65.2 75,798 55,024 72.6 77,275 67,931 87.9 91,886 63,589 69.2 93,058 74,882 80.5
Narok 118,162 38,804 32.8 35,012 27,921 79.7 36,256 32,923 90.8 35,500 31,249 88.0 41,334 32,490 78.6 34,775 32,666 93.9
Nyamira 164,404 48,828 29.7 59,437 57,408 96.6 54,120 63,910 118.1 61,591 58,937 95.7 63,272 56,670 89.6 57,215 55,698 97.3
T. Taveta 81,081 18,208 22.5 23,244 19,074 82.1 24,752 22,441 90.7 23,014 23,848 103.6 26,530 23,220 87.5 20,243 19,892 98.3
Vihiga 205,795 45,988 22.3 51,791 44,419 85.8 65,090 50,714 77.9 62,954 45,096 71.6 66,890 46,254 69.1 68,776 46,527 67.7
Wajir -nt -nt -nt 13,661 2,608 19.1 -nt -nt -nt 0 1,948 100 0 70 100 0 1,317 100
Overall 5,056,530 1,364,710 21.6 1,652,818 1,362,510 82.4 1,570,074 1,442,299 91.9 1,620,185 1417,008 87.5 1,604,858 1,246,301 75.0 1,638,173 1,297,106 84.8
SAC Group
Bomet 426,116 361,835 84.9 358,918 292,936 81.6 341,674 304,609 89.2 377,363 300,454 79.6 333,515 288,149 86.4 312,436 289,645 92.7
Bungoma 766,796 574,830 75.0 777,099 592,771 76.3 787,615 639,544 81.2 894,388 678,926 75.9 785,497 610,156 77.7 714,089 634,390 88.8
Busia 382,859 304,959 79.7 409,262 317,705 77.6 395,103 328,738 83.2 410,675 331,658 80.8 370,401 329,959 89.1 336,662 323,716 96.2
Garissa -nt -nt -nt 30,753 19,103 62.1 -nt -nt -nt 16,280 12,421 76.3 2,391 869 36.3 12,509 10,621 84.9
Homa Bay 558,461 390,599 69.9 550,726 393,454 71.4 532,667 402,400 75.5 536,013 408,226 76.2 489,698 412,220 84.2 477,135 421,617 88.4
Kakamega 823,239 655,996 79.7 832,176 662,831 79.7 811,909 684,524 84.3 859,097 688,322 80.1 854,928 679,122 79.4 778,803 720,725 92.5
Kericho 261,274 219,434 84.0 355,599 270,531 76.1 333,436 292,384 87.7 359,788 296,361 82.4 329,547 297,105 90.2 312,472 297,698 95.3
Kilifi 467,662 386,498 82.6 528,382 387,276 73.3 509,419 388,605 76.3 483,697 395,238 81.7 507,925 348,150 68.5 458,002 377,011 82.3
Kisii 629,268 485,344 77.1 584,798 448,239 76.6 526,545 466,241 88.5 570,673 483,819 84.8 518,861 475,058 91.6 505,358 467,867 92.6
Kisumu 425,619 325,997 76.6 432,260 316,014 73.1 397,356 323,971 81.5 404,793 325,678 80.5 432,915 325,620 75.2 416,778 342,801 82.3
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































pre-treatment undifferentiated STH prevalence and treatment
coverage is outlined in Figure 2A.
Ascaris lumbricoides was the most prevalent STH species
among PSAC during all four survey time points; Y1, 22.5%
(95% CI: 19.3–26.3); Y3, 16.4% (95% CI: 13.5–19.9); Y5, 15.3%
(95% CI: 12.5–18.8); and Y6, 13.9% (95% CI: 10.0–19.4), with a
statistically significant overall relative reduction (RR = 38.2%,
p = 0.003). Counties showed differing levels of A. lumbricoides
prevalence. At Y6, the counties with highest A. lumbricoides
prevalence among PSAC, of over 20% were; Nyamira (45.2%),
Kisii (34.8%), Vihiga (29.0%), Homabay (28.6%), Kakamega
(26.8%), Kericho (21.6%), and Bomet (20.5%). Three counties;
Kisumu, Kwale and Taita Taveta, showed a statistically significant
relative reduction in A. lumbricoides prevalence of over 90%
(Table 3). Comparison of the county-level trends in PSAC pre-
treatment A. lumbricoides prevalence and treatment coverage is
outlined in Figure 2B.
Trichuris trichiurawas the second most prevalent STH species
among PSAC in three of four surveys and least prevalent
in Y1. T. trichiura prevalence was; Y1 5.9% (95% CI: 4.3–
8.1); Y3 4.2% (95% CI: 2.6–6.7); Y5 4.5% (95% CI: 3.0–6.8);
and Y6 4.8% (95% CI: 2.5–9.0), with a non-significant overall
relative reduction (RR = 19.2%, p = 0.426). Overall T. trichiura
prevalence among PSAC appeared to steadily increase after the
initial reduction between Y1 and Y3. Counties showed differing
levels of infection prevalence. At Y6, three counties showed
highest PSAC T. trichiura prevalence of over 20%; Busia (28.6%),
Homabay (28.6%), and Narok (23.0%). Further, during Y6,
nine counties had reduced their prevalence to zero and three
counties i.e., Bomet, Migori, and Nyamira, showed a statistically
significant relative reduction in prevalence of over 90%. However,
infection prevalence increased (significantly) in three counties;
Busia, Homabay, and Kilifi (Table 4). Comparison of the county-
level trends in PSAC pre-treatment T. trichiura prevalence and
treatment coverage is outlined in Figure 2C.
Hookworm was the least prevalent STH detected among
PSAC across all years with the exception of Y1 where it was the
second most. Prevalence of hookworm among PSAC reduced
steadily across all surveys; Y1 13.2% (95% CI: 11.0–15.9); Y3
1.8% (95% CI: 1.1–2.8); Y5 1.2% (95% CI: 0.8–1.9); and Y6 0.5%
(95% CI: 0.2–1.3), with an overall significant relative reduction
(RR = 96.1%, p < 0.001). Although, not representative at
the county level, estimates suggested 16 counties had reduced
hookworm prevalence to zero during the Y6 survey, and the
remaining four counties had prevalence between 1.4 and 2.4%.
This resulted in 13 counties significantly reducing the infection
prevalence by over 90% (Table 5). Comparison of the county-
level trends in PSAC pre-treatment hookworm prevalence and
treatment coverage is outlined in Figure 2D.
SAC Infection Prevalence
Overall, 33.6% (95% CI: 31.2–36.1%), 18.4% (95% CI: 16.2–
20.9%), 14.7% (95% CI: 12.6–17.1%) and 12.5% (95% CI: 10.0–
15.6%) of SAC children were infected with at least one STH
species during Y1, Y3, Y5, and Y6 surveys, respectively, with
an overall significant relative reduction of 62.6% (p < 0.001)
(Table 1). Similarly SAC prevalence of undifferentiated STH
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FIGURE 2 | County-level trend of STH infections prevalence and treatment coverage for year 1 (Y1), year 3 (Y3), year 5 (Y5), and year 6 (Y6) survey time points among
preschool PSAC) and school (SAC) aged group of children in Kenya. The overlay of undifferentiated STH prevalence with treatment coverage is shown in (A), Ascaris
lumbricoides (B), Trichuris trichiura (C), and hookworm (D).
differed within counties with highest prevalence, during Y6,
observed in Vihiga (30.8%) followed by Bomet (24.2%),
Kakamega (23.8%), Busia (23.4%), and Narok (23.1%) and no
infections detected in Garissa and Wajir counties. However,
Kitui, Makueni, and Taita had their prevalence below 1%.
County level relative reduction indicated that only two counties;
Bungoma and Migori, reduced the SAC prevalence by over
90% (Table 1). Comparison of the county-level trends in SAC
pre-treatment undifferentiated STH prevalence and treatment
coverage is outlined in Figure 2A.
Ascaris lumbricoides remained themost prevalent STH species
among SAC during all the four survey time points despite the
prevalence steadily declining. Prevalence for A. lumbricoides was
estimated at; Y1 20.6% (95% CI: 18.1–23.4); Y3 13.7% (95%
CI: 11.8–15.8); Y5 10.5% (95% CI: 8.8–12.6); and Y6 9.4%
(95% CI: 7.2–12.2), with a statistically significant overall relative
reduction (RR = 54.3%, p < 0.001). Further, we noted that the
overall prevalence of A. lumbricoides among SAC was lower than
PSAC prevalence at each respective survey time point. Similarly,
counties showed differing level of infection prevalence. At Y6,
the counties with higher SAC A. lumbricoides prevalence (>20%)
were only Vihiga (30.4%) and Bomet (23.6%). This demonstrated
fewer counties with SAC prevalence >20% compared to PSAC,
who recorded seven counties with prevalence >20%. Only one
county, Kwale, statistically significantly reduced A. lumbricoides
prevalence by over 90% (Table 3). Comparisons of county-level
trends in SAC pre-treatment A. lumbricoides prevalence and
treatment coverage is outlined in Figure 2B.
Trichuris trichiurawas the second most prevalent STH species
among SAC for three surveys but least prevalent during Y1.
Prevalence of T. trichiura for SAC was estimated at; Y1 6.3%
(95% CI: 5.0–8.0); Y3 5.1% (95% CI: 3.8–6.9); Y5 4.6% (95%
CI: 3.4–6.2); and Y6 3.5% (95% CI: 2.2–5.7), with a statistically
significant overall relative reduction (RR = 44.3%, p = 0.005).
The reduction in the T. trichiura prevalence appeared steady
from Y1 to Y6. Counties showed differing levels of prevalence
(Table 4). Comparison of the county-level trends in SAC pre-
treatment T. trichiura prevalence and treatment coverage is
outlined in Figure 2C.
Hookworm was the least prevalent form of STH infection
among SAC in all the surveys except Y1, where it was second.
Prevalence of hookworm among SAC reduced steadily across
all surveys; Y1 15.3% (95% CI: 13.3–17.5); Y3 2.4% (95% CI:
1.8–3.2); Y5 1.3% (95% CI: 1.0–1.7); and Y6 1.0% (95% CI: 0.7–
1.6), with an overall statistically significant relative reduction
(RR = 93.3%, p < 0.001). Overall SAC hookworm prevalence
was higher among SAC than PSAC across all surveys. Similarly,
counties showed differing levels of infection prevalence. Six out of
the 20 counties reduced hookworm prevalence to zero during the
Y6 survey, and remaining counties showed prevalence between
0.2 and 5.7%. Ten counties significantly reduced prevalence
by over 90% (Table 5). Comparison of the county-level trends
in SAC pre-treatment hookworm prevalence and treatment
coverage is outlined in Figure 2D.
Correlations Between Prevalence and
Treatment Coverage for PSAC Group
Data from all surveys suggested significant but a weak negative
correlation between treatment coverage and undifferentiated
STH prevalence (r = −0.144, p = 0.002) (Table 6). At Years 3
and 5, no overall significant correlation was observed while at
Y6, undifferentiated STH was significantly but weakly positively
correlated with treatment coverage (r = 0.277, p < 0.001).
Differing county-level correlations for undifferentiated STHwere
observed over all time points and during Y3, Y5, and Y6, as











































TABLE 3 | Preschool (PSAC) and school (SAC) aged pre-treatment prevalence % (95% CI) and relative reductions % (Wald test: Z-statistic, p-value) for Ascaris lumbricoides infection in 20 counties in Kenya.
County Year 1 Year 3 Year 5 Year 6 Relative Reduction
(Year 1–Year 6)
RR% (Wald test, p-value)
PSAC SAC PSAC SAC PSAC SAC PSAC SAC PSAC SAC
Bomet 40.9 (26.0–64.5) 27.5 (18.6–40.7) 27.3 (14.7–50.6) 20.4 (13.1–31.9) 16.5 (9.7–28.1) 15.0 (8.7–25.9) 20.5 (13.8–30.4) 23.6 (15.9–35.1) 49.9 (Z = −2.39,
p = 0.017)*
14.3 (Z = −0.59,
p = 0.553)
Bungoma 26.9 (14.6–49.4) 28.6 (19.9–41.0) 20.6 (12.8–33.1) 7.9 (6.5–9.6) 15.2 (9.3–24.8) 5.4 (3.2–9.0) 6.8 (1.7–27.6) 4.7 (2.5–8.8) 74.8 (Z = −1.89,
p = 0.058)
83.5 (Z = −6.40,
p < 0.001)*
Busia 22.0 (12.2–39.9) 14.1 (10.2–19.3) 15.3 (9.9–23.8) 15.4 (12.1–19.6) 9.6 (5.3–17.5) 6.8 (4.9–9.5) 7.1 (2.7–18.9) 4.6 (1.7–12.3) 67.6 (Z = −2.15,
p = 0.032)*
67.0 (Z = −2.40,
p = 0.017)*
Garissa -ns -ns -ns -ns -ns -ns 0 0 -ns -ns
Homa Bay 18.0 (12.5–26.0) 17.2 (12.0–24.8) 14.2 (8.7–23.1) 11.2 (6.9–18.4) 5.8 (2.5–13.5) 7.9 (4.5–13.9) 28.6 (12.3–66.2) 16.3 (10.4–25.8) Increase (58.6%,
p = 0.264)
5.2 (Z = −0.22,
p = 0.825)




Kericho 34.8 (25.9–46.8) 23.2 (15.6–34.6) 20.8 (13.8–31.5) 14.1 (9.2–21.8) 26.1 (17.9–38.0) 16.9 (10.8–26.7) 21.6 (18.4–25.4) 15.8 (12.3–20.1) 37.8 (Z = −2.91,
p = 0.004)*
32.1 (Z = −1.89,
p = 0.059)
Kilifi 0 1.1 (0.4–3.2) 0 0.7 (0.1–4.8) 0 0.4 (0.1–2.5) 0 0.5 (0.1–1.5) 0 57.4 (Z = −0.99,
p = 0.323)
Kisii 37.6 (26.3–53.9) 39.9 (32.2–49.4) 34.1 (28.5–40.8) 24.7 (18.6–32.8) 25.6 (18.5–35.6) 22.7 (16.8–30.5) 34.8 (24.2–49.9) 19.0 (11.7–30.7) 7.6 (Z = −0.34,
p = 0.737)
52.4 (Z = −3.76,
p < 0.001)*
Kisumu 9.9 (5.5–18.0) 7.3 (4.7–11.4) 0 2.7 (1.7–4.4) 1.3 (0.1–11.6) 1.7 (1.0–3.0) 0 1.1 (0.6–2.1) 100 (Z = −8.18,
p < 0.001)*
84.3 (Z = −6.26,
p < 0.001)*
Kitui -ns -ns -ns -ns -ns -ns 0 0 -ns -ns
Kwale 2.0 (0.3–15.4) 0.5 (0.2–1.3) 0 0.5 (0.2–1.8) 0 0 0 0 100 (Z = −6.58,
p < 0.001)*
100 (Z = −11.62,
p < 0.001)*
Makueni -ns -ns -ns -ns -ns -ns 0 0 -ns -ns
Migori 0.8 (0.1–5.4) 3.9 (2.1–7.3) 1.2 (0.2–8.1) 1.4 (0.8–2.6) 3.9 (0.7–21.9) 1.4 (0.6–3.2) 3.0 (1.1–8.2) 1.1 (0.5–2.6) Increase (284.8%,
p = 0.246)
72.3 (Z = −2.47,
p = 0.013)*
Mombasa 0 1.8 (1.2–2.6) 0 0 0 0 0 0.4 (0.1–3.6) 0 75.5 (Z = −1.22,
p = 0.223)
Narok 30.3 (17.5–52.6) 29.7 (20.8–42.5) 13.3 (4.8–36.7) 20.9 (15.6–28.1) 26.5 (13.8–50.8) 19.2 (10.9–33.7) 16.4 (4.1–66.3) 12.0 (5.9–24.6) 45.9 (Z = −1.09,
p = 0.277)
59.6 (Z = −3.46,
p = 0.001)*
Nyamira 32.7 (21.0–50.8) 26.9 (18.4–39.5) 29.9 (19.8–45.0) 18.2 (13.4–24.8) 30.3 (23.1–39.8) 16.1 (11.9–21.9) 45.2 (35.4–57.6) 18.8 (10.4–34.0) Increase (38.2%,
p = 0.094)
30.1 (Z = −2.08,
p = 0.037)*




Vihiga 40.0 (33.2–48.2) 45.2 (37.6–54.4) 27.7 (20.3–37.7) 34.6 (25.1–47.6) 38.8 (23.5–63.9) 28.2 (17.3–45.8) 29.0 (16.9–49.8) 30.4 (18.7–49.6) 27.4 (Z = −1.12,
p = 0.263)
32.7 (Z = −2.12,
p = 0.034)*
Wajir -ns -ns -ns -ns -ns -ns 0 0 -ns -ns
Overall 22.5 (19.3–26.3) 20.6 (18.1–23.4) 16.4 (13.5–19.9) 13.7 (11.8–15.8) 15.3 (12.5–18.8) 10.5 (8.8–12.6) 13.9 (10.0–19.4) 9.4 (7.2–12.2) 38.2 (Z = −2.97,
p = 0.003)*
54.3 (Z = −7.01,
p < 0.001)*
-ns Indicates counties which had not had routine parasitological monitoring, hence, surveys were not conducted in these counties during Year 1, Year 3, and Year 5 assessments.


























































































TABLE 4 | Preschool (PSAC) and school (SAC) aged pre-treatment prevalence % (95%CI) and relative reductions % (Wald test: Z-statistic, p-value) for Trichuris trichiura infection in 20 counties in Kenya.
County Year 1 Year 3 Year 5 Year 6 Relative Reduction
(Year 1–Year 6)
RR% (Wald test, p-value)
PSAC SAC PSAC SAC PSAC SAC PSAC SAC PSAC SAC
Bomet 9.1 (5.2–15.8) 3.7 (1.8–7.2) 7.1 (3.4–14.8) 5.7 (2.7–11.7) 5.0 (1.9–13.1) 4.4 (2.7–7.2) 0 1.2 (0.3–4.7) 100 (Z = −8.49,
p < 0.001)*
66.9 (Z = −1.96,
p = 0.050)
Bungoma 0 0.9 (0.5–1.7) 0 0 0 0.2 (0.1–0.8) 0 0 0 100 (Z = −14.21,
p < 0.001)*




Garissa -ns -ns -ns -ns -ns -ns 0 0 -ns -ns
Homa Bay 4.3 (2.4–7.7) 6.0 (4.3–8.4) 0.9 (0.2–3.6) 3.1 (2.1–4.7) 1.7 (0.2–12.3) 3.0 (1.8–4.8) 28.6 (12.3–66.2) 4.6 (2.5–8.2) Increase (569.8%,
p < 0.001)**
24.6 (Z = −0.98,
p = 0.326)




Kericho 6.2 (2.6–14.7) 4.5 (2.4–8.6) 7.3 (1.9–28.5) 3.8 (2.1–6.7) 5.5 (1.9–16.0) 4.8 (2.6–9.0) 2.7 (0.1–14.2) 1.2 (0.6–2.3) 56.5 (Z = −0.82,
p = 0.413)
73.2 (Z = −3.46,
p = 0.001)*




Kisii 2.0 (0.5–7.6) 1.3 (0.7–2.3) 0 1.2 (0.4–3.3) 1.7 (0.4–7.3) 0.9 (0.5–1.6) 4.3 (1.3–14.2) 1.1 (0.4–2.8) Increase (195.6%,
p = 0.128)
12.4 (Z = −0.23,
p = 0.815)
Kisumu 6.6 (2.6–16.8) 3.6 (1.9–6.9) 1.1 (0.2–7.4) 2.2 (1.4–3.4) 2.6 (0.6–12.2) 1.8 (1.1–3.1) 7.1 (1.2–41.4) 1.9 (0.7–5.6) Increase (7.7%,
p = 0.928)
47.0 (Z = −1.06,
p = 0.289)
Kitui -ns -ns -ns -ns -ns -ns 0 0 -ns -ns
Kwale 6.1 (1.8–21.0) 6.3 (4.0–9.8) 1.9 (0.3–12.1) 3.3 (1.1–10.1) 3.2 (1.3–7.9) 1.6 (0.7–4.0) 12.1 (7.0–21.1) 3.4 (1.2–9.8) Increase (98.0%,
p = 0.264)
45.8 (Z = −1.14,
p = 0.252)
Makueni -ns -ns -ns -ns -ns -ns 0 0 -ns -ns




Mombasa 14.6 (3.7–58.6) 17.9 (9.7–33.3) 10.5 (7.7–14.3) 1.8 (0.5–6.9) 0 1.8 (0.2–17.7) 3.0 (0.5–17.6) 0.9 (0.3–2.8) 79.3 (Z = −1.53,
p = 0.127)
95.1 (Z = −5.08,
p < 0.001)*
Narok 31.3 (19.9–49.2) 29.9 (20.8–43.1) 29.3 (19.3–44.5) 26.5 (17.3–40.6) 26.5 (14.4–48.7) 29.1 (21.2–40.0) 23.0 (12.9–40.7) 13.6 (7.0–26.4) 26.7 (Z = −1.26,
p = 0.208)
54.6 (Z = −2.73,
p = 0.006)*
Nyamira 3.0 (0.4–21.6) 3.1 (0.6–16.6) 0 0.5 (0.3–1.0) 0 0.4 (0.1–1.9) 0 0.9 (0.2–3.8) 100 (Z = −3.48,
p = 0.001)*
70.8 (Z = −0.99,
p = 0.323)
T. Taveta 0 2.1 (0.7–5.9) 0 0 2.9 (0.3–33.4) 0 0 0 0 100 (Z = −7.31,
p < 0.001)*
Vihiga 8.2 (2.4–28.7) 10.2 (5.3–19.7) 3.1 (0.5–19.9) 7.6 (4.0–14.5) 7.5 (3.8–14.8) 6.5 (2.6–16.5) 3.2 (0.5–22.9) 8.1 (3.8–17.3) 60.8 (Z = −1.82,
p = 0.068)
21.2 (Z = −0.87,
p = 0.386)
Wajir -ns -ns -ns -ns -ns -ns 0 0 -ns -ns
Overall 5.9 (4.3–8.1) 6.3 (5.0–8.0) 4.2 (2.6–6.7) 5.1 (3.8–6.9) 4.5 (3.0–6.8) 4.6 (3.4–6.2) 4.8 (2.5–9.0) 3.5 (2.2–5.7) 19.2 (Z = −0.80,
p = 0.426)
44.3 (Z = −2.82,
p = 0.005)*
-ns Indicates counties which had not had routine parasitological monitoring, hence, surveys were not conducted in these counties during Year 1, Year 3, and Year 5 assessments.
*Indicates statistically significant relative reductions since Year 1 (noting that this could be a reflection of sampling technique, and noting also that oftentimes reductions have not been sustained).


























































































TABLE 5 | Preschool (PSAC) and school (SAC) aged pre-treatment prevalence % (95%CI) and relative reductions % (Wald test: Z-statistic, p-value) for hookworm infection in 20 counties in Kenya.
County Year 1 Year 3 Year 5 Year 6 Relative Reduction (Year 1 –
Year 6) RR% (Wald test, p-value)
PSAC SAC PSAC SAC PSAC SAC PSAC SAC PSAC SAC
Bomet 0 0.2 (0–0.6) 0 0.1 (0–0.6) 0 0.1 (0–0.6) 0 0 0 100 (Z = −9.42,
p < 0.001)*
Bungoma 45.2 (34.8–58.5) 44.0 (37.0–52.3) 1.0 (0.1–8.0) 1.7 (0.7–4.4) 0.8 (0.1–5.0) 0.8 (0.4–1.7) 1.7 (0.3–11.3) 0 96.2 (Z = −3.52,
p < 0.001)*
100 (Z = −9.29,
p < 0.001)*
Busia 16.1 (10.5–24.6) 21.0 (16.7–26.4) 4.5 (2.1–9.9) 3.0 (1.8–5.0) 1.2 (0.4–3.4) 3.0 (2.0–4.4) 0 1.2 (0.2–8.6) 100 (Z = −8.43,
p < 0.001)*
94.2 (Z = −3.05,
p = 0.002)*
Garissa -ns -ns -ns -ns -ns -ns 0 0 -ns -ns
Homa Bay 8.5 (5.1–14.2) 15.8 (12.9–19.3) 6.2 (3.6–10.6) 5.1 (3.4–7.7) 1.7 (0.5–5.5) 2.7 (1.4–5.2) 0 5.7 (2.8–11.7) 100 (Z = −9.45,
p < 0.001)*
63.8 (Z = −2.90,
p = 0.004)*
Kakamega 27.1 (20.0–36.8) 22.2 (16.7–29.4) 0 0.9 (0.4–1.7) 2.0 (0.7–6.2) 0.3 (0.1–0.8) 2.4 (0.3–19.2) 2.7 (2.1–3.4) 91.0 (Z = −2.49,
p = 0.013)*
88.0 (Z = −12.12,
p < 0.001)*
Kericho 5.6 (2.2–14.0) 5.9 (3.1–11.1) 1.0 (0.2–6.5) 0 0 0.2 (0–0.7) 0 0.4 (0.1–3.0) 100 (Z = −6.15,
p < 0.001)*
93.1 (Z = −3.08,
p = 0.002)*
Kilifi 28.0 (18.6–42.1) 31.2 (29.3–33.1) 0 3.2 (2.2–4.7) 0 1.1 (0.9–1.3) 0 0.7 (0.2–2.8) 100 (Z = −6.12,
p < 0.001)*
97.8 (Z = −5.52,
p < 0.001)*
Kisii 9.9 (4.5–21.9) 11.0 (7.0–17.3) 0 1.5 (0.9–2.6) 0.9 (0.1–6.1) 0.9 (0.5–1.4) 1.4 (0.2–9.2) 0.2 (0–1.7) 85.4 (Z = −2.26,
p = 0.024)*
98.0 (Z = −3.83,
p < 0.001)*
Kisumu 11.0 (5.3–23.2) 7.9 (5.0–12.5) 1.1 (0.2–7.2) 0.3 (0.1–1.3) 0 0.7 (0.3–1.8) 0 0.2 (0–1.4) 100 (Z = −5.81,
p < 0.001)*
97.6 (Z = −4.11,
p < 0.001)*
Kitui -ns -ns -ns -ns -ns -ns 0 0.4 (0.1–1.3) -ns -ns
Kwale 20.4 (11.6–36.0) 25.8 (18.8–35.4) 5.8 (2.9–11.4) 13.8 (8.7–22.1) 3.7 (2.5–5.6) 3.0 (2.0–4.6) 0 3.0 (1.4–6.4) 100 (Z = −5.49,
p < 0.001)*
88.5 (Z = −5.95,
p < 0.001)*
Makueni -ns -ns -ns -ns -ns -ns 0 0.6 (0.2–2.1) -ns -ns
Migori 16.5 (10.1–27.2) 20.8 (16.5–26.0) 0 0.8 (0.4–1.5) 0 0.4 (0.2–1.1) 1.5 (0.2–10.7) 0.6 (0.2–2.3) 90.8 (Z = −2.39,
p = 0.017)*
96.9 (Z = −5.23,
p < 0.001)*
Mombasa 4.9 (0.5–52.0) 7.9 (1.8–35.3) 0 0.7 (0.3–1.7) 0 0 0 0.9 (0.1–6.0) 100 (Z = −2.50,
p = 0.012)*
88.9 (Z = −1.95,
p = 0.052)
Narok 4.0 (1.6–10.0) 5.3 (2.3–11.8) 0 0.9 (0.5–1.7) 1.2 (0.1–10.3) 1.3 (0.6–2.7) 0 0 100 (Z = −6.96,
p < 0.001)*
100 (Z = −7.15,
p < 0.001)*
Nyamira 5.0 (1.3–18.7) 1.6 (0.6–4.1) 0 0.4 (0.2–0.9) 0 0.1 (0–0.7) 0 0.5 (0.1–3.3) 100 (Z = −4.44,
p < 0.001)*
70.8 (Z = −1.22,
p = 0.224)
T. Taveta 0 0 0 0 0 0 0 0 0 0
Vihiga 17.6 (10.2–30.6) 15.7 (8.8–27.9) 0 2.0 (1.1–3.8) 2.7 (1.0–7.6) 2.1 (0.9–5.0) 0 1.0 (0.5–1.9) 100 (Z = −6.17,
p < 0.001)*
93.6 (Z = −4.91,
p < 0.001)*
Wajir -ns -ns -ns -ns -ns -ns 0 0 -ns -ns
Overall 13.2 (11.0–15.9) 15.3 (13.3–17.5) 1.8 (1.1–2.8) 2.4 (1.8–3.2) 1.2 (0.8–1.9) 1.3 (1.0–1.7) 0.5 (0.2–1.3) 1.0 (0.7–1.6) 96.1 (Z = −6.73,
p < 0.001)*
93.3 (Z = −12.34,
p < 0.001)*
-ns Indicates counties which had not had routine parasitological monitoring, hence, surveys were not conducted in these counties during Year 1, Year 3, and Year 5 assessments.


























































































TABLE 6 | Overall and survey time point correlations between pre-treatment undifferentiated STH prevalence of infection and previous year treatment coverage by county among pre-school (PSAC) and school (SAC)
aged group of children in Kenya.
County/survey$ Overall
(All time points)
Year 3 Year 5 Year 6
Correlation(r), p-value Correlation(r), p-value Correlation(r), p-value Correlation(r), p-value
PSAC SAC PSAC SAC PSAC SAC PSAC SAC
Bomet r = –0.266, p = 0.043* r = –0.341, p < 0.001* r = –0.482, p = 0.037* r = –0.718,
p < 0.001*◦
r = −0.186, p = 0.491 r = –0.698, p < 0.001* r = 0.503, p = 0.045# r = 0.229, p = 0.456
Bungoma r = –0.354, p = 0.013* r = –0.525, p < 0.001* r = –0.171, p = 0.594 r = –0.374, p = 0.226 r = 0.081, p = 0.808 r = –0.134, p = 0.693 r = –0.566, p = 0.015* r = 0.187, p = 0.734
Busia r = –0.075, p = 0.580 r = –0.189, p = 0.127 r = 0.255, p = 0.343 r = –0.038, p = 0.861 r = –0.199, p = 0.095 r = –0.522, p < 0.001* Insufficient obs Insufficient obs
Garissa -ns -ns -ns -ns -ns -ns Insufficient obs Insufficient obs
Homa Bay r = –0.034, p = 0.793 r = –0.169, p = 0.279 r = 0.272, p = 0.023# r = 0.232, p = 0.251 r = –0.098, p = 0.674 r = –0.077, p = 0.718 Insufficient obs r = –0.831,
p < 0.001*◦
Kakamega r = –0.366, p = 0.004* r = –0.383, p < 0.001* r = 0.516, p < 0.001# r = 0.014, p = 0.956 r = –0.394, p = 0.022* r = –0.552, p < 0.001* r = 0.196, p = 0.600 r = –0.429, p = 0.201
Kericho r = –0.205, p = 0.341 r = –0.159, p = 0.477 r = 0.029, p = 0.933 r = –0.253, p = 0.287 r = –0.033, p = 0.910 r = –0.167, p = 0.528 r = 0.450, p = 0.028 r = –0.637, p = 0.011*
Kilifi r = –0.543, p = 0.024* r = 0.357, p < 0.001# Insufficient obs Insufficient obs Insufficient obs Insufficient obs Insufficient obs r = –0.209, p = 0.329
Kisii r = –0.186, p = 0.180 r = –0.467, p < 0.001* r = 0.152, p = 0.664 r = –0.253, p = 0.150 r = –0.188, p = 0.540 r = –0.147, p = 0.636 r = –0.712,
p < 0.001*◦
r = 0.415, p = 0.108
Kisumu r = –0.507, p < 0.001* r = 0.162, p = 0.082 r = 0.327, p = 0.028# r = 0.847, p < 0.001#◦ r = –0.471, p = 0.060 r = –0.642, p < 0.011* r = 0.086, p = 0.792 r = 0.100, p = 0.443
Kitui -ns -ns -ns -ns -ns -ns Insufficient obs Insufficient obs
Kwale r = –0.266, p = 0.018* r = 0.312, p < 0.001# r = 0.095, p = 0.689 r = –0.776,
p < 0.001*◦
r = 0.111, p = 0.640 r = 0.695, p < 0.001* Insufficient obs Insufficient obs
Makueni -ns -ns -ns -ns -ns -ns Insufficient obs Insufficient obs
Migori r = –0.712,
p < 0.001*◦
r = 0.584, p = 0.001# Insufficient obs Insufficient obs Insufficient obs Insufficient obs Insufficient obs Insufficient obs
Mombasa r = –0.481, p < 0.001* r = 0.114, p = 0.421 Insufficient obs r = –0.461, p = 0.242 Insufficient obs r = 0.500, p = 0.182 r = –0.250, p = 0.191 r = –0.250, p = 0.342
Narok r = –0.443, p = 0.003* r = 0.218, p = 0.183 r = –0.449, p = 0.043* r = –0.759,
p < 0.001*◦
r = –0.552, p = 0.020* r = –0.420, p = 0.081 Insufficient obs Insufficient obs
Nyamira r = 0.011, p = 0.950 r = 0.164, p = 0.140 r = –0.326, p = 0.047* r = 0.225, p = 0.111 r = –0.342, p = 0.034 r = 0.060, p = 0.599 r = –0.222, p = 0.552 r = 0.345, p = 0.216
Taita Taveta r = –0.185, p = 0.684 r = –0.670, p < 0.001* Insufficient obs Insufficient obs Insufficient obs Insufficient obs Insufficient obs r = –0.980,
p < 0.001*◦
Vihiga r = –0.462, p < 0.001* r = –0.487, p = 0.025* r = –0.614, p = 0.002* r = –0.633, p = 0.016* r = –0.681, p < 0.001* r = –0.632, p = 0.007* r = –0.236, p = 0.669 r = –0.286, p = 0.515
Wajir -ns -ns -ns -ns -ns -ns Insufficient obs Insufficient obs
Overall r = –0.144, p = 0.002* r = 0.053, p = 0.409 r = 0.114, p = 0.096 r = –0.136, p = 0.121 r = –0.105, p = 0.241 r = –0.160, p = 0.088 r = 0.277, p < 0.001# r = 0.330, p < 0.001#
$Year 1 correlations were not included since there was no previous treatment coverage to compare with the Year 1 prevalence.
-ns Indicates counties which had not had routine parasitological monitoring, hence, surveys were not conducted in these counties during Year 1, Year 3, and Year 5 assessments.
* Indicates a statistically significant negative correlation.
# Indicates a statistically significant positive correlation.
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shown in Table 6. In one county, Migori, there was a strong
(r > 0.7) significant negative correlation between prevalence
and treatment coverage overall; nine other counties had a weak
(r < 0.7) significant negative correlation overall. Ten of the
20 counties showed no overall significant correlation. At Y3,
no strong significant negative or positive correlation was seen
in any county, but weak negative and positive correlations
were seen in four and three counties, respectively. At Y5,
no strong correlations were seen as well, but weak negative
correlations were seen in three counties. At Y6, a strong negative
correlation was seen in Kisii (r = −0.712, p < 0.001), with weak
negative correlation seen in Bungoma County and strong positive
correlation seen in Bomet County. Whilst the general trend
amongst those correlations that were significant was for negative
rather than positive correlations, only two counties, Narok
and Vihiga, showed statistically significant negative correlations
across each consecutive time point (Y3 and Y6). Further,
frequently there were insufficient PSAC observations to analyze
correlations at county level at separate time points.
For differentiated STH across all time points, treatment
coverage was only significantly (but weakly) negatively correlated
with hookworm infection (r = −0.307, p < 0.001) while
no significant correlations were found between either A.
lumbricoides (r =−0.081, p= 0.111) or T. trichiura (r =−0.016,
p = 0.697) and treatment coverage. Across all time points,
hookworm was strongly, significantly and negatively correlated
with treatment coverage in two counties; Kilifi (r = −0.809,
p < 0.001) and Migori (r = −0.716, p < 0.001), but weakly,
significantly and negatively correlated with treatment coverage
in 10 counties. A. lumbricoides was weakly, significantly and
negatively correlated with treatment coverage in three counties;
Narok (r = −0.319, p = 0.011), Taita Taveta (r = −0.501,
p = 0.039), and Vihiga (r = −0.420, p < 0.001). Similarly,
T. trichiura was weakly, significantly and negatively correlated
with treatment coverage in two counties; Mombasa (r =−0.481,
p < 0.001) and Vihiga (r = −0.286, p = 0.003), and weakly,
significantly and positively correlated in two counties; Kilifi
(r = 0.100, p = 0.009) and Taita Taveta (r = 0.296, p = 0.034)
(Table 7).
County-level correlations, for each specific survey time
point, for the differentiated STH infections are outlined in
the Supplementary Table 1. Over all counties, A. lumbricoides
prevalence had a significant weak positive correlation with
treatment coverage at the Y6 survey (r = 0.325, p < 0.001)
(Supplementary Table 1); there were no other significant
correlations (either negative or positive) over all counties seen
for any species at any other survey time points. By county, the
only strong correlation seen was in Y6 in Kisii, where a significant
positive correlation was seen (r = 0.824, p = 0.001). Whilst
other significant negative or positive, correlations were seen
within counties at different time points, they were weak, with
again no trend emerging across time points for any differentiated
STH within any county. Often, there were again insufficient
observations to assess this at county level by time point.
Ascaris lumbricoides infection was weakly, significantly
and negatively correlated with treatment coverage in Bomet
(r = −0.664, p < 0.001), Nyamira (r = −0.326, p = 0.047), and
Vihiga (r = −0.614, p = 0.002) counties during Y3; Kakamega
(r = −0.376, p = 0.030), Kisii (r = −0.545, p = 0.028),
Nyamira (r = −0.342, p = 0.034), and Vihiga (r = −0.669,
p < 0.001) during Y5; and Bungoma (r = −0.604, p = 0.014)
and Kisii (r = −0.625, p = 0.002) during Y6. However, it was
significantly positively correlated with the treatment coverage
in Busia (r = 0.471, p = 0.010) and Kakamega (r = 0.516,
p < 0.001) counties during Y3, and Bomet (r = 0.503,
p = 0.045) and Kericho (r = 0.450, p = 0.028) during Y6
(Supplementary Table 1).
Hookworm infection showed weak significant negative
correlations only in Busia County (r = −0.326, p = 0.048)
during Y3; in Homabay (r = −0.312, p = 0.006), and Kakamega
(r = −0.224, p = 0.049) during Y5 survey. However, no
significant (negative or positive) correlation was observed during
Y6 survey (Supplementary Table 1).
Trichuris trichiura showed weak significant negative
correlations in Kericho (r = −0.400, p = 0.016) and Narok
(r = −0.459, p = 0.041) counties during Y3 survey; in Kisii
(r = −0.504, p = 0.014) and Narok (r = −0.597, p = 0.001)
during Y5 survey; and a strong negative correlation in Kisii
County (r = −0.824, p < 0.001) during Y6 survey. However, it
showed a significant positive correlation in Homabay (r = 0.200,
p= 0.020) during Y3 (Supplementary Table 1).
Geographical distribution of undifferentiated STH pre-
treatment prevalence overlaid with the previous year’s treatment
coverage for the PSAC group is shown in Figure 3, the figure
helped to visualize the PSAC county and/or subcounty level
correlations between prevalence and treatment coverage. Even
though, it can be observed that the PSAC prevalence appeared
to have reduced over the years, it was still high especially in
many areas inWestern parts of Kenya. Further, we noted that the
treatment coverage during all the survey years was high (>75%),
however, this high coverage did not clearly translate to low PSAC
prevalence in the respective areas.
Correlations Between Prevalence and
Treatment Coverage for SAC Group
Table 6 outlines the correlations between pre-treatment
undifferentiated STH prevalence and previous year’s treatment
coverage among SAC for Y3, Y5, and Y6 surveys. A weak
significant positive correlation was observed during Y6
(r = 0.330, p < 0.001), this indicated that prevalence of STH
continued to increase even as coverage increased. Nonetheless,
these overall correlations mask underlying negative and positive
county-level correlations. In overall, weak negative county-level
correlations were observed in Bomet (r = −0.482, p = 0.037),
Bungoma (r = −0.525, p < 0.001), Kakamega (r = −0.383,
p < 0.001), Kisii (r = −0.467, p < 0.001), Taita Taveta
(r = −0.670, p < 0.001), and Vihiga (r = −0.487, p = 0.025),
with a weak positive correlation in three counties; Kilifi, Kwale,
and Migori. During Y3 survey, strong negative correlations were
observed in Bomet (r = −0.718, p < 0.001), Kwale (r = −0.776,
p < 0.001), and Narok (r = −0.759, p < 0.001), and weak
negative correlation in Vihiga, and further, a strong positive
correlation observed in Kisumu (r = 0.847, p < 0.001). During
Y5 survey, no strong correlation was observed but weak negative
correlations were observed in six counties. During Y6 survey,
strong negative correlations were observed in two counties;















































A. lumbricoides Hookworm T. trichiura
PSAC SAC PSAC SAC PSAC SAC
Bomet r = –0.230, p = 0.077 r = –0.330, p = 0.001* Insufficient obs r = 0.057, p = 0.247 r = –0.119, p = 0.523 r = –0.241, p = 0.187
Bungoma r = –0.312, p = 0.053 r = –0.587, p = 0.001* r = –0.347, p = 0.002* r = –0.501, p = 0.001* Insufficient obs r = –0.303, p = 0.133
Busia r = –0.078, p = 0.562 r = –0.105, p = 0.372 r = –0.436, p < 0.001* r = 0.279, p = 0.052 r = 0.085, p = 0.293 r = –0.465, p < 0.001*
Garissa Insufficient obs Insufficient obs Insufficient obs Insufficient obs Insufficient obs Insufficient obs
Homa Bay r = –0.072, p = 0.607 r = –0.206, p = 0.238 r = –0.110, p = 0.157 r = 0.016, p = 0.876 r = 0.042, p = 0.689 r = –0.148, p = 0.391
Kakamega r = –0.221, p = 0.067 r = –0.233, p = 0.041* r = –0.672, p < 0.001* r = –0.484, p < 0.001* r = –0.093, p = 0.235 r = –0.001, p = 0.990
Kericho r = –0.165, p = 0.451 r = –0.189, p = 0.394 r = –0.181, p = 0.029* r = 0.101, p = 0.382 r = –0.186, p = 0.191 r = –0.157, p = 0.506
Kilifi Insufficient obs r = –0.023, p = 0.955 r = –0.809, p < 0.001*◦ r = 0.451, p < 0.001# r = 0.100, p = 0.009# r = –0.184, p = 0.069
Kisii r = 0.017, p = 0.918 r = –0.416, p = 0.004* r = –0.579, p < 0.001* r = –0.308, p < 0.001* r = –0.045, p = 0.638 r = –0.132, p = 0.343
Kisumu r = –0.278, p = 0.283 r = 0.095, p = 0.290 r = –0.491, p < 0.001* r = 0.211, p < 0.001# r = –0.048, p = 0.821 r = 0.046, p = 0.740
Kitui Insufficient obs Insufficient obs Insufficient obs Insufficient obs Insufficient obs Insufficient obs
Kwale r = –0.082, p = 0.131 r = 0.184, p = 0.008# r = –0.208, p = 0.037* r = –0.358, p < 0.001* r = –0.177, p = 0.169 r = –0.010, p = 0.943
Makueni Insufficient obs Insufficient obs Insufficient obs Insufficient obs Insufficient obs Insufficient obs
Migori r = 0.112, p = 0.555 r = 0.280, p = 0.009# r = –0.716, p < 0.001*◦ r = 0.590, p < 0.001# r = –0.289, p = 0.053 r = 0.222, p = 0.057
Mombasa Insufficient obs r = 0.092, p = 0.313 r = –0.384, p < 0.001* r = –0.033, p = 0.862 r = –0.481, p < 0.001* r = –0.070, p = 0.763
Narok r = –0.319, p = 0.011* r = 0.274, p = 0.037# r = –0.037, p = 0.494 r = 0.237, p = 0.093 r = –0.230, p = 0.116 r = –0.090, p = 0.671
Nyamira r = –0.089, p = 0.632 r = 0.177, p = 0.125 r = –0.341, p = 0.006* r = –0.014, p = 0.826 r = –0.270, p = 0.055 r = 0.013, p = 0.694
Taita Taveta r = –0.501, p = 0.039* r = 0.137, p = 0.091 Insufficient obs Insufficient obs r = 0.296, p = 0.034# r = –0.711, p < 0.001*◦
Vihiga r = –0.420, p < 0.001* r = –0.507, p = 0.021* r = –0.243, p = 0.005* r = 0.152, p = 0.038# r = –0.286, p = 0.003* r = –0.459, p = 0.007*
Wajir Insufficient obs Insufficient obs Insufficient obs Insufficient obs Insufficient obs Insufficient obs
Overall r = –0.081, p = 0.111 r = –0.119, p = 0.101 r = –0.307, p < 0.001* r = –0.044, p = 0.320 r = –0.016, p = 0.697 r = 0.030, p = 0.506
$Year 1 correlations were not included since there was no previous treatment coverage to compare with the Year 1 prevalence.
*Indicates a statistically significant negative correlation.
# Indicates a statistically significant positive correlation.
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FIGURE 3 | Geographical distribution of the undifferentiated STH pre-treatment prevalence overlaid with the previous year treatment coverage (A: Year 1, B: Year 3,
C: Year 5, and D: Year 6) for the preschool aged (PSAC) group of children in Kenya.
Homabay (r =−0.831, p < 0.001) and Taita Taveta (r =−0.980,
p < 0.001), with a weak negative correlation in Kericho.
Overall correlations between Ascaris lumbricoides infection
prevalence and treatment coverage is shown in Table 7, and
this overall correlation was non-significant. However, five
counties; Bomet, Bungoma, Kakamega, Kisii, and Vihiga showed
weak significant negative correlations, while Kwale and Migori
indicated a weak significant positive correlation (Table 7).
Specific survey time point correlations are shown in the
Supplementary Table 1. During Y3 survey, strong significant
negative correlations were observed in Bomet (r = −0.727,
p < 0.001) and Kisumu (r = −0.721, p = 0.047), a weak
significant negative correlation in Vihiga (r=−0.613, p= 0.029).
During Y5, weak significant negative correlations were observed
in Bomet (r = −0.670, p < 0.001), Kakamega (r = −0.527,
p < 0.001), Kisumu (r = −0.608, p = 0.013), and Vihiga
(r =−0.645, p= 0.004). During Y6, a strong significant negative
correlation was observed in Taita Taveta (r =−0.980, p < 0.001),
and weak significant negative correlation in Kericho (r=−0.675,
p= 0.002) (Supplementary Table 1).
Overall correlation between hookworm infection prevalence
and treatment coverage is shown in Table 7, and this overall
correlation was non-significant. However, five counties; Bomet,
Bungoma, Kakamega, Kisii, and Vihiga showed overall weak
significant negative correlations, while Kilifi, Kisumu, Migori,
and Vihiga indicated a weak significant positive correlation
(Table 7). Specific survey time point correlations are shown in
the Supplementary Table 1. During Y3 survey, weak significant
negative correlations were observed in Kwale (r = −0.626,
p = 0.003) and Mombasa (r = −0.100, p = 0.001), and
a weak significant positive correlation in Busia (r = 0.456,
p= 0.005), and Kisumu (r = 0.676, p < 0.001). During Y5, weak
significant negative correlations were observed in Kakamega
(r = −0.431, p < 0.001) and Narok (r = −0.421, p = 0.008),
while weak significant positive correlations were observed in
Busia (r = 0.692, p < 0.001), Kericho (r = 0.495, p = 0.009),
Kisii (r = 0.556, p = 0.014), and Kwale (r = −0.497, p = 0.010).
During Y6, weak significant negative correlations were observed
in Kakamega (r = −0.461, p = 0.048) and Vihiga (r = −0.670,
p < 0.001) (Supplementary Table 1).
Overall correlation between Trichuris trichiura infection
prevalence and treatment coverage is shown in Table 7, and this
overall correlation was non-significant. However, one county;
Taita Taveta (r =−0.711, p < 0.001), showed a strong significant
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negative correlation, while Busia and Vihiga showed weak
significant negative correlations (Table 7). Specific survey time
point correlations are shown in Supplementary Table 1. During
Y3 survey, strong significant negative correlations were observed
in Kisii (r = −0.708, p < 0.001) and Kwale (r = −0.967,
p < 0.001), and weak significant negative correlations in Narok
(r = −0.637, p < 0.001), and Vihiga (r = −0.617, p < 0.001).
During Y5, a strong significant negative correlation was observed
in Narok (r = −0.706, p < 0.001) and strong significant positive
correlations in Kwale (r = 0.798, p < 0.001) and Nyamira
(r = 0.946, p < 0.001). Further, weak significant negative
correlations were observed in Bomet, Busia, Kakamega, and
Vihiga. During Y6, a strong significant negative correlation
was observed in Homabay (r = −0.903, p < 0.001), and
weak significant negative correlations in Kisii and Mombasa
(Supplementary Table 1).
Geographical distribution of undifferentiated STH pre-
treatment prevalence overlaid with the previous year’s treatment
coverage for the SAC group is shown in Figure 4, the figure
helped to visualize the SAC county and/or subcounty level
correlations between prevalence and treatment coverage. From
the figure, it can be observed that the SAC prevalence had
reduced tremendously over the years, in most subcounties, the
treatment coverage was high (>75%). Actually, in most areas
especially during Y6 where the treatment coverage was above
75%, the prevalence was seen to be below 20% (these areas can
be analogously viewed as portraying negative correlations). On
the other hand, some areas did show high prevalence of 20% and
above despite their subcounty treatment coverage being above
75% (these areas can be seen to portray positive correlations).
However, there was no clear pattern of this correlation in
the map, indicating heterogeneity in the subcounty/county
correlation analysis.
Minimum Coverage for Sustained
Reductions in Prevalence
Analysis of the minimum treatment coverage required to
ensure a reduction of the infection prevalence over time
for both age groups was demonstrated by use of the non-
linear relationship curves. Observed non-linear relationships
between STH prevalence and previous year treatment coverage
is shown in Figure 5. From the figure, it was observed that
for program-wide reduction of undifferentiated STH in both
PSAC and SAC, a likely minimum treatment coverage of 82%
is required. Additionally, for each differentiated STH species,
likely minimum treatment coverage of 85% for hookworm, 84%
for A. lumbricoides, and 74% for T. trichiura is required to
be maintained.
Change Point Analysis
Change point analysis was performed to investigate the survey
year points associated with significant changes in prevalence
following the previous year(s) MDA. From this analysis, it was
determined that a significant change in PSAC undifferentiated
prevalence occurred during Y2 survey (i.e., after one round of
MDA) for all the STH infections except T. trichiura, which didn’t
show any significant change points in prevalence (Figure 6).
Additionally, the change points associated with the SAC
infection prevalence occurred during Y2 survey time point
for undifferentiated STH and hookworm infection, while for
A. lumbricoides it occurred during Y3 (i.e., after two rounds
of MDA). Similarly, there was no significant change points
associated with T. trichiura (Figure 7).
DISCUSSION
In this study, we quantified the correlation between the
observed school level STH prevalence and treatment coverage,
in order to understand how treatment coverage influenced
observed reduction or increase in prevalence at county level.
Past mathematical models have predicted that high sustained
treatment coverage levels (above 75%) in low and medium
transmission settings can eventually result in transmission
interruption, but in high transmission areas the high coverage
needs to be coupled with biannual treatment frequency and
extended to include adults, in order to achieve transmission
interruption (28). In addition, we provided analysis comparing
the STH infections prevalence among PSAC and SAC groups of
children within schools participating in M&E activities of the
Kenyan NSBD program at four key evaluation survey time points
following 6 years of sustained annual mass treatment. This will
provide information to Kenyan STH control programs about
STH burden among the two most vulnerable populations in the
country. Previous studies of data from M&E activities as part
of the NSBD program have focused on infection burden in the
general school going children population without disaggregation
between these two critical age groups (14–17).
Average treatment coverage through all six surveys was
reportedly above 78%, which exceeds the WHO minimum
effective treatment coverage level of 75% (19). In each age
group, the yearly treatment coverage was also above 75%
with the exception of PSAC during Y1 where coverage was
only an average of 21.6% across counties. This was likely due
to the initially low awareness of the program only offering
treatment to enrolled children resulting in non-enrolled PSAC, a
likely substantial proportion, being left untreated. County-level
treatment coverage among each age group was heterogeneous
and varied from year to year. Efforts should bemade by the NSBD
program to ensure that county level treatment coverage remains
above the WHO recommended thresholds.
PSAC and SAC Infection Prevalence
After 6 years of MDA and rigorous M&E, we found that 17.9%
of PSAC and 12.5% of SAC were infected with at least one
STH infection, noting that both groups of children had similar
infection burdens just prior to the implementation of the NSBD
program (Y1). Our analysis suggested a slightly higher infection
burden among PSAC than SAC. The fact that PSAC children
still harbor a higher burden of STH infection points to a missed
opportunity for treating this vulnerable group of children by
STH control programs during deworming activity. Consideration
should be given to increasing the deworming coverage for PSAC.
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FIGURE 4 | Geographical distribution of the undifferentiated STH pre-treatment prevalence overlaid with the previous year treatment coverage (A: Year 1, B: Year 3,
C: Year 5, and D: Year 6) for the school aged (SAC) group of children in Kenya.
Prevalence of differentiated STH infections differed across age
structures, with A. lumbricoides being prevalent among PSAC
while hookworm and T. trichiura being predominant among
SAC across all surveys. This finding is in line with the current
research pointing to an increase in hookworm and T. trichiura
prevalence and intensity with age (29–31). This suggests that the
NSBD program might have had less impact on the community-
wide prevalence where these two infections are likely be common,
especially among adults (32, 33). As suggested in previous
studies, a large burden of STH infections are likely harbored in
adults, underscoring the importance of potentially broadening
treatment coverage to encompass the general community (28,
32).
An overall significant decline in prevalence for
undifferentiated STH infections and specifically for hookworm
and A. lumbricoides in both groups of children was observed,
however, prevalence reductions for T. trichiura were only
significant among SAC and not significant among PSAC.
Previous studies have shown that single dose oral albendazole
is efficacious against these two species of STH (34–36), but
likely less efficacious against T. trichiura (34–37). Again, the
observed non-significant reductions especially for T. trichiura
could be due to the changing treatment coverage levels among
each group of children, and differing county level coverage as
well as considerable fluctuations in coverage targets and reported
coverage within counties over time. For significant prevalence
reductions to be observed for T. trichiura, higher treatment
coverage levels may be warranted. Alternately dual drug therapy
involving ivermectin co-administered with albendazole or
mebendazole may be effective (38).
Correlations Between Prevalence and
Treatment Coverage for PSAC and SAC
Groups
Correlational analysis suggested that prevalence reduced as
treatment coverage increased ormaintained at sufficient coverage
level. Counterintuitively however, other analyses suggested
infection prevalence increased or remained high despite high (or
an increase in) treatment coverage. This suggests that increases
in treatment coverage alone are not sufficient to influence
reductions in infection prevalence. This finding is emphasized
if a sudden increase in treatment coverage is followed a spell of
consistently low coverage levels.
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FIGURE 5 | Non-linear relationship between STH infections prevalence (A: Undifferentiated STH, B: Ascaris lumbricoides, C: Hookworm, and D: Trichuris trichiura)
and treatment coverage for year 1, year 3, and year 6 survey time points among the general children population (both PSAC and SAC combined) in Kenya. Note that
Year 1 was not displayed since there was no previous year treatment coverage to compare with the baseline prevalence.
Correlational analyses are useful for investigating the
relationship between STH prevalence and MDA coverage,
however these remain non-causal. As a general rule, under the
methods followed in this study, correlations of r < 0.7 are
seen as relatively weak with too much potential for chance or
confounding to be interpreted as meaningful. For this reason,
even where statistically significant, weak correlations coupled
with small sample sizes are particularly problematic to interpret.
Insufficient sample sizes especially at the county level were a
major barrier in this study. In the analyses that were conducted,
the “overall” (all counties, all time points) correlations remain
most reliable for inferring potential relationships, largely due to
larger sample sizes.
Overall, across all survey time points, significant negative
correlations between infection prevalence and treatment
coverage were observed for undifferentiated STH infections
among PSAC, however not for SAC. This suggests that treatment
coverage directly affects reductions in PSAC prevalence.
This finding however, may be influenced by relatively few
PSAC being included in the M&E surveys, compared to their
SAC counterparts.
County level correlations were observed between increased
coverage in MDA and reductions in prevalence; for both
PSAC and SAC in Bomet, Bungoma, Kakamega, and Vihiga
counties; for PSAC only in Kilifi, Kwale, Mombasa, Kisumu,
and Migori; and for SAC only in Kisii and Taita Taveta.
The observed significant negative correlations in the coastal
counties of Kilifi, Kwale, Mombasa, and Taita Taveta may be
attributed to additional community-wide treatments provided
by other partner programs that used albendazole. For instance,
the Kenyan Lymphatic filariasis Elimination Program has
annually provided, on average, 10 rounds of antifilarial tablets;
diethylcarbamazine citrate (DEC) and albendazole to the entire
at-risk populations aged 2 years and above for community-wide
treatment and control of Lymphatic filariasis in six counties
of the coastal region since 2002 (39). Similarly, observed
significant negative correlations in western region counties,
especially Bungoma, Kakamega, and Vihiga, may be attributed
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FIGURE 6 | Change point analysis using binary segmentation method for the pre-treatment prevalence (%) among the preschool aged (PSAC) group of children in
Kenya.
to supplementary treatment, and revamped water, sanitation and
hygiene (WASH) interventions by the WASH Benefits Study
which provided interventions to households in 702 villages
between November 2012 and May 2014 (40). These examples
of additional treatment by partner programs illustrate that the
provision of school-based deworming coupled with community
based treatment, as well as contemporary interventions like
WASH, may lead to achievement of significant reductions
in prevalence.
Statistically significant correlations between increased
coverage, and also increases in prevalence were mostly
observed during Y6 survey for both PSAC and SAC for
undifferentiated STH and specifically for A. lumbricoides. The
positive correlations observed during this particularly survey
year can be mainly attributed to the fact that many areas had
received treatment below 75% during the past immediate MDA
round compared to the preceding MDAs. Also, prevalence
across many schools were still high at above 20%. County
level significant positive correlations were observed in few
counties such as Migori, Homabay, and Kisumu. Most of these
counties had histories of limited additional interventions from
partner programs and generally relied solely on school-based
deworming as a mainstay control measure. This points to the
fact that school deworming alone is not sufficient to provide high
treatment coverage necessary to maintain sustained reductions
in prevalence over long time periods.
The absence of a more pronounced relationship between
increasing/maintained coverage and prevalence decreases may
be explained by the non-linear relationship between infection
prevalence and treatment coverage as outlined in Figure 5. What
we see from this figure is that treatment coverage likely needs to
be maintained above a critical minimum level in order to achieve
a sustained reduction in prevalence. We note that, minimum
coverage level varies by survey time point as well as individual
STH species. However, for the possible elimination of STH as a
public health problem by treatment alone, minimum treatment
coverage needs to be maintained above 85%. We appreciate
that, our findings differ from theWHO recommended minimum
coverage level of 75% (19). However, this is expected as infection
levels in Kenya have substantially reduced since the inception
of the NSBD program and therefore higher treatment coverage
levels are necessary to “mob up” remaining prevalence.
Among PSAC, low coverage coupled with small sample
sizes especially at county level, essentially resulted in a lack of
statistical power to conduct correlation analysis at county-level
and likely contributed to variability across results. It should
further be noted that the prevalence surveys used in this analysis
were not designed for county-level analyses, and are themselves
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FIGURE 7 | Change point analysis using binary segmentation method for the pre-treatment prevalence (%) among the school aged (SAC) group of children in Kenya.
insufficiently powered at the county level for strong conclusions
to be drawn. As county level treatment coverage among PSAC
was well-below 75% at most time points, and the proportion of
PSAC at each time point represented treatment-naïve children
who would have only just become old enough to start receiving
treatments, it is not possible to conclude that a lack of reduction
in prevalence is due to resurgence of infection between MDA
rounds. However, these results do indicate that there are either
considerable numbers of untreated PSAC and/or that there is
high transmission occurring from the environment in which
these children live.
The emergence of very few strong correlations at county
levels could be possibly due to variability between levels of
treatment coverage and infection prevalence across different
counties year-on-year, accompanied by generally low numbers
both for coverage and prevalence at county level, negating the
opportunities to find correlations both within and across time
points. Lack of statistical power at county level, notwithstanding,
this analysis has enabled us to identify areas which could benefit
from more focused activities like detailed qualitative research
in counties like Homabay, Kisumu, Migori, and other counties
which showed positive correlations, either overall or at specific
time points, especially among SAC. Such research would enable a
greater understanding of why prevalence continues to rise despite
relatively high coverage levels.
Change Point Analysis
Drawing from our change point analysis, there was a significant
change in undifferentiated STH prevalence, specifically
hookworm, after one round of MDA (where the change
point occurred at Y2) in both groups of children. However,
hookworm prevalence in subsequent years (i.e., after Y2) did not
vary sufficiently to warrant detection of any change. This finding
on hookworm suggests the high efficacy of treatment using
albendazole on both PSAC and SAC, which has been widely
demonstrated in other studies (34–36).
Change points associated with A. lumbricoides were observed
during Y2 (for PSAC) and Y3 (for SAC). Again this finding
suggests that albendazole is highly efficacious against this
particular infection (34–36), and that the NSBD program has
been able to significantly reduce the parasites prevalence after
only 2 to 3 rounds of MDA in both groups. It is worthwhile
to note that change point in the SAC group took a little longer
to be realized and this could be as a result of the high levels
of re-infections that are often associated with A. lumbricoides
(37). Going forward, the NSBD program should take measures
to address the issue of A. lumbricoides re-infections.
Finally, we did not observe any change points associated
with T. trichiura infection (i.e., no detectable significant changes
in prevalence over the years). As described above, the use
of albendazole as the main anthelminthic drug by the NSBD
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program would unlikely lead to any significant reduction in T.
trichiura. For T. trichiura to be eliminated as a public health
problem, a drug combination needs to be used (38).
Study Strengths and Limitations
The main strength of this study was the ability to gather 6-
year data from a large scale deworming programme in Kenya.
It is our view the results presented in this study will be
important in promoting MDA throughout Kenya, especially the
age-differentiated MDA.
However, this study was not without limitations: (I) The
schools surveyed by the M&E program since 2012 were
sampled and statistically powered to detect changes in infection
prevalence at the national and regional levels only. Introduction
of devolution in 2013 after the start of the program, yielded
the county system essentially by merging and/or splitting the
existing districts. Hence, at this stage, county level analysis
becomes insufficiently powered to give firm conclusions at
county level due to the resulting small sample sizes and the
inconsistent number of schools. (II) There were relatively few
PSAC treated as well as examined for STH infections at each
school location, this is because this group of children were
not the main target of the program and were not necessarily
enrolled in the participating schools and the program did not
offer treatment or even conduct sample collection at household
level, where they reside, rather these were done at school level.
Hence, PSAC included in this study were majority drawn from
children attending ECD classes as well as those who happen to be
present in school during either treatment or sample collection.
(III) The program used the Kato-Katz technique for examination
of STH eggs in line with the WHO guidelines for examination
of these infections in high endemic settings (18), however, this
technique has previously been shown to be less sensitive in low
endemic areas (41), which is particularly salient during years 5
and 6 in which prevalence reduced substantially. Therefore, the
prevalence estimates presented here may be an under-estimation
of the true population prevalence. (IV) Finally, it is important
to note that the NSBD program currently only follows schools
longitudinally and not individual children.
CONCLUSIONS
In this article, we have provided detailed information on PSAC
and SAC infection prevalence, treatment coverage, relative
reductions in prevalence, and correlation analysis between
treatment coverage and infection prevalence. Our findings
showed an initially higher burden of STH infections among both
groups of children which declined steadily over the survey years.
Significant negative correlations in some counties indicated that
prevalence reduced over time as treatment coverage increased
or remained at a sufficiently high level as previously determined
by WHO. The absence of many strong significant negative
correlations might be attributed to several factors including low
baseline infection prevalence and/or low treatment coverage
preventing elucidation of correlations, or other factors, not
measured in this analysis, such as an insufficient number of
treatment rounds, reinfections, insufficientWASH access, and/or
reduced drug efficacy among other possible factors. Finally, for
the first time in Kenya, the overlay of treatment coverage and
prevalence data indicated that there are minimum treatment
coverage thresholds needed to achieve a negative relationship
ensuring that prevalence will decline as coverage increases, this
imply that administration of MDA may be most impactful if
applied at county level and maintained above key thresholds.
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APPENDIX
A1. The statistical correlations between infection prevalence and the previous year’s treatment coverage were fitted using a structural
equation model (SEM) of the following structure (Figure A1):
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